As of 2024-12-15, the Relative Valuation of MYND Life Sciences Inc (MYND.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 CAD, the upside of MYND Life Sciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-11-29 | -3.31 |
| 2024-11-28 | -3.31 |
| 2024-11-27 | -3.31 |
| 2024-11-26 | -2.60 |
| 2024-11-21 | -3.55 |
| 2024-11-20 | -2.36 |
| 2024-11-19 | -2.36 |
| 2024-11-18 | -6.62 |
| 2024-11-14 | -2.36 |
| 2024-11-13 | -2.36 |
| 2024-11-12 | -2.36 |
| 2024-11-11 | -2.36 |
| 2024-11-08 | -1.89 |
| 2024-11-07 | -1.65 |
| 2024-11-06 | -1.89 |
| 2024-11-04 | -1.42 |
| 2024-10-31 | -1.42 |
| 2024-10-30 | -0.95 |
| 2024-10-28 | -0.95 |
| 2024-10-23 | -0.95 |
| 2024-10-21 | -1.18 |
| 2024-10-17 | -1.18 |
| 2024-10-02 | -0.47 |
| 2024-09-30 | -0.95 |
| 2024-09-27 | -0.95 |
| 2024-09-23 | -1.65 |
| 2024-09-20 | -1.65 |
| 2024-09-06 | -1.89 |